Geneva, Oct. 21 -- International Clinical Trials Registry received information related to the study (RBR-7yrysy5) titled 'Assessment of the presence of protection against yellow fever in children and adults after administration of reduced doses of the 17dd-yellow fever vaccine' on Oct. 2.

Study Type: Observational

Primary Sponsor: Instituto Rene Rachou da Fundacão Oswaldo Cruz

Condition: Yellow fever vaccine C01.920.852.875

Intervention: This is a cross-sectional, comparative, observational study conducted in children and adults of both genders that received the 17DD yellow fever primary vaccination employing a reduced dose in 2018, as participants in the study "Humoral and Cellular Immunity in Children and Adults After 17DD Ye...